The Application of an Institutional Clinical Data Warehouse to the Assessment of Adverse Drug Reactions (ADRs)
The Application of an Institutional Clinical Data Warehouse to the Assessment of Adverse Drug Reactions (ADRs)
复制标题
DOI:
10.1160/me0374
复制
发表时间:
2007
影响因子:
1.7
通讯作者:
Qiyan Zhang;Y. Matsumura;Tadamasa Teratani;S. Yoshimoto;T. Mineno;K. Nakagawa;M. Nagahama;S. Kuwata;H. Takeda
中科院分区:
文献类型:
--
作者:
Qiyan Zhang;Y. Matsumura;Tadamasa Teratani;S. Yoshimoto;T. Mineno;K. Nakagawa;M. Nagahama;S. Kuwata;H. Takeda
Summary Objectives: To apply an institutional clinical data warehouse (CDW) to the assessment of adverse drug reactions (ADRs) and demonstrate its utility through a specific example. Methods: We modeled the process for assessing ADRs through retrospective cohort design by using CDW at the Osaka University Hospital as follows: 1) We defined a drug X, an adverse drug reaction (ADR) Y, and a laboratory measurement Z to assess Y during a given study period; 2) we excluded those whose Z value exceeded the defined criteria or were not available at the inception of the cohort; 3) we divided the patients into two groups based on exposure or non-exposure to X; 4) we matched the patient characteristics between the two groups through stratification and randomization; and 5) we compared the frequency of patients who presented Y during the study period between the two groups. Aminoglycoside and Cephalosporin associated nephrotoxicity in pediatric inpatients was used as an example to demonstrate the usefulness of this approach. Results: Our evaluation indicates that there is an increased risk of nephrotoxicity for pediatric inpatients who were prescribed cephalosporin either alone or in combination with aminoglycoside; further, aminoglycoside tends to increase the cephalosporin-associated nephrotoxicity. Conclusions: Our findings are consistent with those drawn from other studies, indicating thatthe method of a pplying an institutional CDW is useful for assessing ADRs.